Remex Baltic OÜ
Remex Baltic OÜ is Osaühing. The main activity is Lepinguline toitlustusteenus jm toitlustamine (56221). The company is located in Harju maakond. Founded 30/01/2018. Share capital is 2,508 €. 2024 figures: revenue 1,085 €, profit 0 €, employees 0. The company is on the tax debtors list.
Key figures
- Year
- 2024
- Revenue
- 1,085 €
- Net profit
- 0 €
- Employees
- 0
Signals
Financials
2024: revenue 1,085 €, net profit 0 €.